MeiraGTx Holdings (MGTX) Gains from Investment Securities (2018)

MeiraGTx Holdings (MGTX) posted Gains from Investment Securities of $2.2 million for Q2 2018, up 426.29% on a QoQ basis from -$669408.0 in Q1 2018.

MeiraGTx Holdings (MGTX) Gains from Investment Securities (2018) Analysis & Trends

MeiraGTx Holdings' Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $2.2 million for Q2 2018.

Quarterly Gains from Investment Securities changed N/A year-over-year to $2.2 million in Q2 2018, while the trailing twelve-month figure through Dec 2018 was $1.5 million (changed N/A YoY) and the FY2018 annual result came in at $1.5 million, up 225.32% from the prior year.
Gains from Investment Securities was $2.2 million for Q2 2018 at MeiraGTx Holdings, up from -$669408.0 in the prior quarter.
Across five years, Gains from Investment Securities topped out at $2.2 million in Q2 2018 and bottomed at -$669408.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	MeiraGTx Holdings	997.33 Mn	931.40 Mn	-

Download Data